Facebook Instagram Linkedin-in Youtube

Gada Italia updates

News

GADA Italia and Inari Medical: exclusive distribution in treatment of pulmonary embolism and peripheral circulation

June 22, 2021 /

New hope for INOCA patients suffering from angina

June 11, 2021 /

Impella 2.5: safe hemodynamic support in patients undergoing combined PCI and BAV

April 4, 2019 /

The impact of Neovasc Reducer on ischemic burden and myocardial perfusion: the JACC article

February 4, 2019 / ,

STEMI: a study published on Circulation confirms the efficiency of Impella CP on unloading the left ventricle

January 18, 2019 / ,

New partnership between GADA Italia and Lifetech Scientific Corporation

January 10, 2019 / ,

Neovasc Reducer™: clinical results in microvascular angina

January 8, 2019 /

The European experience of ACURATE neo in bicuspid and tricuspid aortic valves

December 17, 2018 / ,

Gada and Principia SGR announce a new partnership

October 30, 2018 /

VA ECMO-Impella Association: pulmonary flow improvement and effective left ventricular discharge

September 24, 2018 / ,

1-Year Outcomes of the using of the ACURATE neo transcatheter heart valve in 1,000 Patients

September 13, 2018 / ,

BIOTRAC, healthcare traceability solution, has its web page

July 6, 2018 /

Bactiguard: a new support against blood stream infections

May 18, 2018 / ,

The contribute of Impella during high-risk unprotected left main PCI

May 3, 2018 / ,

CE Mark for Terumo Ultimaster TANSEI

April 24, 2018 / ,

Percutaneous coronary intervention (PCI): CE marked indications for Terumo Ultimaster

April 24, 2018 / ,

CE Mark for Terumo Ultimaster TANSEI

April 24, 2018 / ,

CE Mark for LivaNova VNS Therapy SenTiva Generator

April 18, 2018 / ,

Antibiotics: use with care

March 30, 2018 / ,

New solutions for interventional systems: the agreement between Terumo and Medeon Biodesign

March 5, 2018 / ,

Impella: approval for expanded FDA indication for high risk percutaneous coronary intervention (PCI) procedures

February 22, 2018 / ,

Augmented Reality (AR) for transfusion and infusion: the AccuVein technology

February 21, 2018 / ,

Chemo-embolization: Terumo LifePearl® approved as a Class III device

January 30, 2018 / ,

The vital contribution of Impella® before revascularization

November 27, 2017 / ,

18 November 2017 – 10th European Antibiotic Awareness Day (EAAD)

November 17, 2017 / ,

New clinical study on Bactiguard’s central venous catheter shows promising results

November 10, 2017 / ,

Bactiguard and GADA: a new partnership for Italy

June 15, 2017 / ,

Dialysis: VitabranE, efficient aid to the management of anaemia

March 23, 2017 / ,

Transfusion: the debut of BIOTRAC at SIMTI

March 23, 2017 / ,

Impella 2.5: the results of Circulation Research study

March 16, 2017 / ,

Abiomed and Impella: historical result in the U.S.A.

March 14, 2017

Perfusionist and communication: the interview of GSD Magazine to Giulio Pavan (EPS)

March 7, 2017 / ,

Siena CEC: the latest news from cardiovascular

March 2, 2017 / ,

International Epilepsy Day

February 13, 2017 / ,

FDA: a new recognition for Abiomed

January 23, 2017 / ,

Important agreement between Terumo Corporation, Abbott and St. Jude Medical Ltd.

December 15, 2016 / ,

ECMO\ECLS: Gada in partnership with St. Jude Medical and Chalice Medical

November 29, 2016 / ,

SICCH 2016: Gada was present with its partners

November 28, 2016 / ,

GISE 2016: interventional cardiology at the Porto Antico of Genoa

October 17, 2016 / ,

Gada: the new web site is on line

July 11, 2016 /

GADA launches its newly expanded EPS Integrated Healthcare Services

July 11, 2016 / ,

EuroPCR 2016: a major new study on DAPT post-stent

May 18, 2016 / ,

Symetis announced the results for the SAVI TF Registry

May 17, 2016 / ,

The Abiomed Impella Therapy approved by FDA

April 8, 2016 / ,
Recent Posts
Categories

Copyright ©2021 GADA Italia Spa - VAT 08230471008